Global Nanoemulsions 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR012504247

Publication Date:

January 14, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Nanoemulsions market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.
In USA, EU, Japan, China, India and Southeast Asia, Nanoemulsions key players include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, etc.
USA is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent.
In terms of application, the largest application is Pharmaceutical Industrial, with a share over 45%, followed by Cosmetic Industrial, Food Industrial, etc.
This report is a detailed and comprehensive analysis for global Nanoemulsions market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nanoemulsions market size and forecasts, in consumption value ($ Million), 2020-2031
Global Nanoemulsions market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Nanoemulsions market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Nanoemulsions market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nanoemulsions
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nanoemulsions market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical, GlaxoSmithKline, Novartis AG, Sanofi, B. Braun Melsungen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Nanoemulsions market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Steroids
Anesthetics
NSAIDs
Immunosuppressant
Antiretroviral
Antimicrobials
Vasodilators
Others
麻豆原创 segment by Application
Pharmaceutical Industrial
Cosmetic Industrial
Food Industrial
Others
麻豆原创 segment by players, this report covers
Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nanoemulsions product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nanoemulsions, with revenue, gross margin, and global market share of Nanoemulsions from 2020 to 2025.
Chapter 3, the Nanoemulsions competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Nanoemulsions market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nanoemulsions.
Chapter 13, to describe Nanoemulsions research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Nanoemulsions by Type
1.3.1 Overview: Global Nanoemulsions 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Nanoemulsions Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Steroids
1.3.4 Anesthetics
1.3.5 NSAIDs
1.3.6 Immunosuppressant
1.3.7 Antiretroviral
1.3.8 Antimicrobials
1.3.9 Vasodilators
1.3.10 Others
1.4 Global Nanoemulsions 麻豆原创 by Application
1.4.1 Overview: Global Nanoemulsions 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical Industrial
1.4.3 Cosmetic Industrial
1.4.4 Food Industrial
1.4.5 Others
1.5 Global Nanoemulsions 麻豆原创 Size & Forecast
1.6 Global Nanoemulsions 麻豆原创 Size and Forecast by Region
1.6.1 Global Nanoemulsions 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Nanoemulsions 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Nanoemulsions 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Nanoemulsions 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Nanoemulsions 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Nanoemulsions 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Nanoemulsions 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Allergan plc
2.1.1 Allergan plc Details
2.1.2 Allergan plc Major Business
2.1.3 Allergan plc Nanoemulsions Product and Solutions
2.1.4 Allergan plc Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Allergan plc Recent Developments and Future Plans
2.2 AbbVie Inc.
2.2.1 AbbVie Inc. Details
2.2.2 AbbVie Inc. Major Business
2.2.3 AbbVie Inc. Nanoemulsions Product and Solutions
2.2.4 AbbVie Inc. Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 AbbVie Inc. Recent Developments and Future Plans
2.3 AstraZeneca Inc.
2.3.1 AstraZeneca Inc. Details
2.3.2 AstraZeneca Inc. Major Business
2.3.3 AstraZeneca Inc. Nanoemulsions Product and Solutions
2.3.4 AstraZeneca Inc. Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 AstraZeneca Inc. Recent Developments and Future Plans
2.4 Fresenius Kabi AG
2.4.1 Fresenius Kabi AG Details
2.4.2 Fresenius Kabi AG Major Business
2.4.3 Fresenius Kabi AG Nanoemulsions Product and Solutions
2.4.4 Fresenius Kabi AG Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Fresenius Kabi AG Recent Developments and Future Plans
2.5 Kaken Pharmaceutical
2.5.1 Kaken Pharmaceutical Details
2.5.2 Kaken Pharmaceutical Major Business
2.5.3 Kaken Pharmaceutical Nanoemulsions Product and Solutions
2.5.4 Kaken Pharmaceutical Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Kaken Pharmaceutical Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Nanoemulsions Product and Solutions
2.6.4 GlaxoSmithKline Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business
2.7.3 Novartis AG Nanoemulsions Product and Solutions
2.7.4 Novartis AG Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Novartis AG Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Nanoemulsions Product and Solutions
2.8.4 Sanofi Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 B. Braun Melsungen
2.9.1 B. Braun Melsungen Details
2.9.2 B. Braun Melsungen Major Business
2.9.3 B. Braun Melsungen Nanoemulsions Product and Solutions
2.9.4 B. Braun Melsungen Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 B. Braun Melsungen Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Nanoemulsions Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Nanoemulsions by Company Revenue
3.2.2 Top 3 Nanoemulsions Players 麻豆原创 Share in 2024
3.2.3 Top 6 Nanoemulsions Players 麻豆原创 Share in 2024
3.3 Nanoemulsions 麻豆原创: Overall Company Footprint Analysis
3.3.1 Nanoemulsions 麻豆原创: Region Footprint
3.3.2 Nanoemulsions 麻豆原创: Company Product Type Footprint
3.3.3 Nanoemulsions 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Nanoemulsions Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Nanoemulsions 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Nanoemulsions Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Nanoemulsions 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Nanoemulsions Consumption Value by Type (2020-2031)
6.2 North America Nanoemulsions 麻豆原创 Size by Application (2020-2031)
6.3 North America Nanoemulsions 麻豆原创 Size by Country
6.3.1 North America Nanoemulsions Consumption Value by Country (2020-2031)
6.3.2 United States Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Nanoemulsions Consumption Value by Type (2020-2031)
7.2 Europe Nanoemulsions Consumption Value by Application (2020-2031)
7.3 Europe Nanoemulsions 麻豆原创 Size by Country
7.3.1 Europe Nanoemulsions Consumption Value by Country (2020-2031)
7.3.2 Germany Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Nanoemulsions Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Nanoemulsions Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Nanoemulsions 麻豆原创 Size by Region
8.3.1 Asia-Pacific Nanoemulsions Consumption Value by Region (2020-2031)
8.3.2 China Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Nanoemulsions Consumption Value by Type (2020-2031)
9.2 South America Nanoemulsions Consumption Value by Application (2020-2031)
9.3 South America Nanoemulsions 麻豆原创 Size by Country
9.3.1 South America Nanoemulsions Consumption Value by Country (2020-2031)
9.3.2 Brazil Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Nanoemulsions Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Nanoemulsions Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Nanoemulsions 麻豆原创 Size by Country
10.3.1 Middle East & Africa Nanoemulsions Consumption Value by Country (2020-2031)
10.3.2 Turkey Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Nanoemulsions 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Nanoemulsions 麻豆原创 Drivers
11.2 Nanoemulsions 麻豆原创 Restraints
11.3 Nanoemulsions Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Nanoemulsions Industry Chain
12.2 Nanoemulsions Upstream Analysis
12.3 Nanoemulsions Midstream Analysis
12.4 Nanoemulsions Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.